Agenus, Inc. (AGEN)
3.16
-0.42
(-11.73%)
USD |
NASDAQ |
May 18, 16:00
3.18
+0.02
(+0.63%)
After-Hours: 05:59
Agenus Research and Development Expense (Quarterly) : 11.82M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 13.75M |
| Amarin Corp. Plc | 4.020M |
| Vertex Pharmaceuticals, Inc. | 961.60M |
| Halozyme Therapeutics, Inc. | 25.56M |
| Protalix Biotherapeutics, Inc. | 5.426M |